MAG‐EPA resolves lung inflammation in an allergic model of asthma
Clinical & Experimental Allergy2013Vol. 43(9), pp. 1071–1082
Citations Over TimeTop 11% of 2013 papers
Abstract
We demonstrate that MAG-EPA reduces airway hyperresponsiveness and lung inflammation in OVA-sensitized animals, a finding consistent with a decrease in IL-4, IL-5, IL-13, COX-2 and MUC5AC expression levels in the lung. The present data suggest that MAG-EPA represents a new potential therapeutic strategy for resolving inflammation in allergic asthma.
Related Papers
- → Eotaxin protein levels and airway pathology in a mouse model for allergic asthma(2002)20 cited
- → Role of L‐arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen‐induced early asthmatic reaction in guinea‐pigs(1999)58 cited
- → Reactive dye induced occupational asthma without nonspecific bronchial hyperreactivity(1990)3 cited
- Bronchial hyperresponsiveness to methacholine in relation to asthma control - Results from the MIDAS study(2013)
- IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term(2013)